abstract |
The present invention relates to radioiodinated vectors, especially radioiodinated radiopharmaceuticals and methods for their preparation. The invention provides methods that enable the preparation and purification of radioiodinated vectors without the need for HPLC purification, as well as novel precursors which include biotin-like substituents useful in such methods. |